| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.17 | 0.6 |
| mRNA | betulinic acid | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.023 | 0.6 |
| mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | 1S,3R-RSL-3 | CTRPv2 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | selumetinib:JQ-1 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | AKT inhibitor VIII | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | 0.044 | 0.6 |